Last reviewed · How we verify

NCT07090577: MOPCAS

Multiomics Profiling of CSF in Cardiac Arrest Survivors

Active, enrolled Last updated 29 July 2025
What this trial tests

trial in Cardiac Arrest (CA) in 15 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
22 July 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorChungnam National University Hospital
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment15
Start date22 July 2025
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across South Korea

Conditions studied

Sponsor

Chungnam National University Hospital

Who can join

18 and older, any sex, with Cardiac Arrest (CA) or Hypoxic-Ischemic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to identify further pathophysiologic mechanism of secondary brain injury following cardiac arrest by using serial multiomics profiling of serum and cerebrospinal fluid (CSF) samples. The main question it aims to answer is: A. The main question it aims to answer is: What are the dynamic molecular changes in serum and CSF that reflect the pathophysiological mechanisms of secondary brain injury after cardiac arrest? B. What are the differences in serum and CSF multiomic signatures between varying severities of cardiac arrest, and how are these differences associated with the underlying pathophysiological mechanisms of secondary brain injury? Serum and CSF samples that have already been prospectively collected from participants and stored in the BioBank will be used for this analysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiac Arrest (CA)

Currently open trials in the same condition.

Other Chungnam National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07090577.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing